| 标题 |
Abstract P5-17-05: A phase I/Ib study of inavolisib (GDC-0077) in combination with fulvestrant in patients (pts) with PIK3CA-mutated hormone receptor-positive/HER2-negative (HR+/HER2-) metastatic breast cancer |
| 网址 | |
| DOI |
10.1158/1538-7445.sabcs21-p5-17-05
doi
|
| 其它 |
期刊:Cancer Research 作者:Dejan Juric; Phillippe L Bedard; Andrés Cervantes; Valentina Gambardella; Mafalda Oliveira; et al 出版日期:2022-02-15 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)